SMTL ID : 4a9y.1

P38ALPHA MAP KINASE BOUND TO CMPD 8

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

monomer

Ligands

1 x AQZ: N-(3-{[7-METHOXY-6-(2-PYRROLIDIN-1-YLETHOXY)QUINAZOLIN-4-YL]AMINO}-4-METHYLPHENYL)-2-MORPHOLIN-4-YLISONICOTINAMIDE(Non-covalent)

AQZ.1: 20 residues within 4Å: Chain A: V.35, G.36, V.43, A.56, K.58, E.76, L.80, M.83, V.88, I.89, T.111, H.112, L.113, M.114, G.115, H.153, I.171, L.172, D.173, F.174 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:V.43, A:A.56, A:K.58, A:E.76, A:L.80, A:T.111, A:L.113, A:D.173 Hydrogen bonds: A:K.58, A:E.76, A:E.76, A:T.111, A:M.114, A:D.173 pi-Stacking: A:F.174 pi-Cation interactions: A:K.58

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Brown, D.S. et al., The Discovery of N-Cyclopropyl-4-Methyl-3-[6--(4-Methylpiperazin-1-Yl-4-Oxoquinazolin-3(4H)-Yl]Benzamide (Azd6703), a Clinical P38Alpha Map Kinase Inhibitor for the Treatment of Inflammatory Diseases. Bioorg.Med.Chem.Lett. (2012)

Release Date

2012-05-16

Peptides

MITOGEN-ACTIVATED PROTEIN KINASE 14: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

MITOGEN-ACTIVATED PROTEIN KINASE 14

Related Entries With Identical Sequence